Product
PF-03446962
1 clinical trial
1 indication
Indication
MesotheliomaClinical trial
A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural MesotheliomaStatus: Completed, Estimated PCD: 2014-04-27
1 clinical trial
1 indication